Erythropoietin: a candidate compound for neuroprotection in schizophrenia (Q28212816)

8

0 references

Werner Maier

12

object named as

W Maier

0 references

author name string

D Degner

2

0 references

J Meller

3

0 references

M Brines

4

0 references

M Béhé

5

0 references

M Hasselblatt

6

0 references

H Woldt

7

0 references

F Knerlich

9

0 references

S Jacob

10

0 references

N von Ahsen

11

0 references

W Brück

13

0 references

E Rüther

14

0 references

A Cerami

15

0 references

W Becker

16

0 references

A-L Sirén

The current status of the dopamine hypothesis of schizophrenia

17

0 references

language of work or name

English

0 references

publication date

January 2004

0 references

published in

Molecular Psychiatry

0 references

volume

9

0 references

page(s)

42-54

0 references

issue

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Negative v positive schizophrenia. Definition and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Intelligence quotient and neuropsychological profiles in patients with schizophrenia and in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Structural neuroimaging in schizophrenia. An integrative view of neuromorphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Longitudinal study of brain morphology in first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Schizophrenia as a disorder of developmentally reduced synaptic connectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Expression of Oct-6, a POU III domain transcription factor, in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Paranoid disorders following war brain damage. Preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Schizophrenia as a disorder of neurodevelopment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

To model a psychiatric disorder in animals: schizophrenia as a reality test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Latent inhibition and conditioning in rat strains which show differential prepulse inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Electrolytic lesions of the medial septum enhance latent inhibition in a conditioned taste aversion paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Neuroprotection--what does it mean?--What means do we have?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Erythropoietin--a novel concept for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

In vivo evidence that erythropoietin protects neurons from ischemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Use of recombinant human erythropoietin as an antianemic and performance enhancing drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

A technique for repeated sampling of CSF from the anesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Hypoxia and hypoxia-inducible factor modulated gene expression in brain: involvement in neuroprotection and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

The nagging question of the function of N-acetylaspartylglutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

21 January 2018

Déja vu all over again.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Survival of hippocampal neurons in culture upon hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

Disturbed Gyrification of the Prefrontal Region in Male Schizophrenic Patients: A Morphometric Postmortem Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

Erythropoietin therapy for acute stroke is both safe and beneficial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

Isolation and culture of adult rat hippocampal neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

Specificity-enhanced hot-start PCR: addition of double-stranded DNA fragments adapted to the annealing temperature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

The distribution of active bone marrow in the adult

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

The modulation of corticoaccumbens transmission by limbic afferents and dopamine: a model for the pathophysiology of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021

Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001442

7 January 2021